Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | PF-573228 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |